149 related articles for article (PubMed ID: 27007879)
1. Recombinant canarypox virus expressing the VP2 protein of infectious bursal disease virus induces protection in vaccinated SPF chickens.
Zanetti FA; Cardona R; Federico CR; Chimeno-Zoth S; Calamante G
Virol Sin; 2016 Jun; 31(3):266-9. PubMed ID: 27007879
[TBL] [Abstract][Full Text] [Related]
2. Canarypox virus expressing infectious bursal disease VP2 protein as immunogen for chickens.
Zanetti FA; Grand MD; Mitarotonda RC; Taboga OA; Calamante G
Braz J Microbiol; 2014; 45(1):231-4. PubMed ID: 24948937
[TBL] [Abstract][Full Text] [Related]
3. Protection against infectious bursal disease virulent challenge conferred by a recombinant avian adeno-associated virus vaccine.
Perozo F; Villegas P; Estevez C; Alvarado IR; Purvis LB; Williams S
Avian Dis; 2008 Jun; 52(2):315-9. PubMed ID: 18646463
[TBL] [Abstract][Full Text] [Related]
4. Avian adenovirus CELO recombinants expressing VP2 of infectious bursal disease virus induce protection against bursal disease in chickens.
Francois A; Chevalier C; Delmas B; Eterradossi N; Toquin D; Rivallan G; Langlois P
Vaccine; 2004 Jun; 22(17-18):2351-60. PubMed ID: 15149796
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of VP2 protein expressed in E. coli for protection against highly virulent infectious bursal disease virus.
Omar AR; Kim CL; Bejo MH; Ideris A
J Vet Sci; 2006 Sep; 7(3):241-7. PubMed ID: 16871018
[TBL] [Abstract][Full Text] [Related]
6. Complete, long-lasting protection against lethal infectious bursal disease virus challenge by a single vaccination with an avian herpesvirus vector expressing VP2 antigens.
Tsukamoto K; Saito S; Saeki S; Sato T; Tanimura N; Isobe T; Mase M; Imada T; Yuasa N; Yamaguchi S
J Virol; 2002 Jun; 76(11):5637-45. PubMed ID: 11991992
[TBL] [Abstract][Full Text] [Related]
7. Development of recombinant VP2 vaccine for the prevention of infectious bursal disease of chickens.
Rong J; Cheng T; Liu X; Jiang T; Gu H; Zou G
Vaccine; 2005 Sep; 23(40):4844-51. PubMed ID: 15979770
[TBL] [Abstract][Full Text] [Related]
8. Neutralizing-antibody-mediated protection of chickens against infectious bursal disease via one-time vaccination with inactivated recombinant Lactococcus lactis expressing a fusion protein constructed from the RCK protein of Salmonella enterica and VP2 of infectious bursal disease virus.
Wang W; Song Y; Liu L; Zhang Y; Wang T; Zhang W; Li K; Qi X; Gao Y; Gao L; Liu C; Zhang Y; Wang Y; Pan Q; He G; Wang X; Cui H
Microb Cell Fact; 2019 Jan; 18(1):21. PubMed ID: 30704494
[TBL] [Abstract][Full Text] [Related]
9. Development of a tailored vaccine against challenge with very virulent infectious bursal disease virus of chickens using reverse genetics.
Gao L; Qi X; Li K; Gao H; Gao Y; Qin L; Wang Y; Wang X
Vaccine; 2011 Jul; 29(33):5550-7. PubMed ID: 21658423
[TBL] [Abstract][Full Text] [Related]
10. Large-scale manufacture and use of recombinant VP2 vaccine against infectious bursal disease in chickens.
Rong J; Jiang T; Cheng T; Shen M; Du Y; Li S; Wang S; Xu B; Fan G
Vaccine; 2007 Nov; 25(46):7900-8. PubMed ID: 17923174
[TBL] [Abstract][Full Text] [Related]
11. Protection of chickens, with or without maternal antibodies, against IBDV infection by a recombinant IBDV-VP2 protein.
Zhou X; Wang D; Xiong J; Zhang P; Li Y; She R
Vaccine; 2010 May; 28(23):3990-6. PubMed ID: 20338216
[TBL] [Abstract][Full Text] [Related]
12. Vaccination with E. coli recombinant empty viral particles of infectious bursal disease virus (IBDV) confer protection.
Rogel A; Benvenisti L; Sela I; Edelbaum O; Tanne E; Shachar Y; Zanberg Y; Gontmakher T; Khayat E; Stram Y
Virus Genes; 2003 Oct; 27(2):169-75. PubMed ID: 14501195
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of two strains of Marek's disease virus serotype 1 for the development of recombinant vaccines against very virulent infectious bursal disease virus.
Li K; Liu Y; Liu C; Gao L; Gao Y; Zhang Y; Cui H; Qi X; Zhong L; Wang X
Antiviral Res; 2017 Mar; 139():153-160. PubMed ID: 27908832
[TBL] [Abstract][Full Text] [Related]
14. Plasmid DNA encoding antigens of infectious bursal disease viruses induce protective immune responses in chickens: factors influencing efficacy.
Li J; Huang Y; Liang X; Lu M; Li L; Yu L; Deng R
Virus Res; 2003 Dec; 98(1):63-74. PubMed ID: 14609631
[TBL] [Abstract][Full Text] [Related]
15. Protective oral vaccination against infectious bursal disease virus using the major viral antigenic protein VP2 produced in Pichia pastoris.
Taghavian O; Spiegel H; Hauck R; Hafez HM; Fischer R; Schillberg S
PLoS One; 2013; 8(12):e83210. PubMed ID: 24376665
[TBL] [Abstract][Full Text] [Related]
16. Active and passive protection against variant and classic infectious bursal disease virus strains induced by baculovirus-expressed structural proteins.
Vakharia VN; Snyder DB; Lütticken D; Mengel-Whereat SA; Savage PK; Edwards GH; Goodwin MA
Vaccine; 1994 Apr; 12(5):452-6. PubMed ID: 8023554
[TBL] [Abstract][Full Text] [Related]
17. Mucosal application of cationic poly(D,L-lactide-co-glycolide) microparticles as carriers of DNA vaccine and adjuvants to protect chickens against infectious bursal disease.
Negash T; Liman M; Rautenschlein S
Vaccine; 2013 Aug; 31(36):3656-62. PubMed ID: 23777953
[TBL] [Abstract][Full Text] [Related]
18. Recombinant Marek's disease virus type 1 provides full protection against very virulent Marek's and infectious bursal disease viruses in chickens.
Li K; Liu Y; Liu C; Gao L; Zhang Y; Cui H; Gao Y; Qi X; Zhong L; Wang X
Sci Rep; 2016 Dec; 6():39263. PubMed ID: 27982090
[TBL] [Abstract][Full Text] [Related]
19. Efficient self-assembly and protective efficacy of infectious bursal disease virus-like particles by a recombinant baculovirus co-expressing precursor polyprotein and VP4.
Lee HJ; Kim JY; Kye SJ; Seul HJ; Jung SC; Choi KS
Virol J; 2015 Oct; 12():177. PubMed ID: 26502988
[TBL] [Abstract][Full Text] [Related]
20. Comparison of homologous and heterologous prime-boost immunizations combining MVA-vectored and plant-derived VP2 as a strategy against IBDV.
Richetta M; Gómez E; Lucero MS; Chimeno Zoth S; Gravisaco MJ; Calamante G; Berinstein A
Vaccine; 2017 Jan; 35(1):142-148. PubMed ID: 27876199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
